Immix Biopharma (IMMX) Capital Expenditures (2021 - 2026)
Immix Biopharma (IMMX) posted Capital Expenditures of $21,043 for Q2 2026, down 83.5% from $127,630 a year earlier and down 35.2% from the prior quarter.
Powered by 
Analysis
Immix Biopharma (IMMX) Capital Expenditures (2021 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Immix Biopharma was $591,111, down 39.3% year-over-year; for FY2025, it came in at $732,925, down 37.8% from FY2024.
- Annual Capital Expenditures shows a four-year compound annual growth rate of 449.8% (FY2021 to FY2025).
- In prior years, Immix Biopharma's Capital Expenditures was $1.18 million in FY2024, $52,089 in FY2023 and $802.00 in FY2021.
- The Q2 2026 figure stands as the lowest quarterly Capital Expenditures since Q4 2023.
- On a year-over-year basis, Capital Expenditures has declined in each of the last three quarters, with an average decline of 35.3% over the last six quarters.
- According to Business Quant data, Capital Expenditures for the three prior quarters was $32,486 (Q1 2026), $165,126 (Q4 2025) and $372,456 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Immix Biopharma | 753.99 Mn | 753.99 Mn | - | 21,043.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21,043.00 |
| Mar 31, 2026 | 32,486.00 |
| Dec 31, 2025 | 165,126.00 |
| Sep 30, 2025 | 372,456.00 |
| Jun 30, 2025 | 127,630.00 |
| Mar 31, 2025 | 67,713.00 |
| Dec 31, 2024 | 507,151.00 |
| Sep 30, 2024 | 271,542.00 |
| Jun 30, 2024 | 97,074.00 |
| Mar 31, 2024 | 301,913.00 |
| Dec 31, 2023 | 13,177.00 |
| Mar 31, 2021 | 802.00 |
API Access
Immix Biopharma Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();